Form 4: Akoya Biosciences Director Transfers Shares to Trusts

Director Robert G. Shepler reports gifting shares of Akoya Biosciences to separate property and gift trusts.

Summary

• Robert G. Shepler, a director of Akoya Biosciences, Inc., filed a Form 4 disclosing changes in his beneficial ownership.
• On March 13, 2024, Shepler transferred 369,592 shares of common stock to the Robert G. Shepler Separate Property Trust of 2008 and 369,592 shares to the RGS Gift Trust.
• The transactions were reported as gifts, with a price of $0.00 per share.
• Shepler disclaims beneficial ownership of the securities held by the RGS Gift Trust, where the trustee is his domestic partner.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. It doesn't inherently convey positive or negative sentiment about the company's performance or prospects.

Management Comments

• Mr. Shepler disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that Mr. Shepler is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the ownership changes of company insiders.

Stakeholder Impact

• The transfer of shares may have a minor impact on the overall shareholder structure, but is unlikely to significantly affect other stakeholders.

Key Dates